Suppr超能文献

利钠肽作为难治性高血压的新靶点

Natriuretic Peptides as a Novel Target in Resistant Hypertension.

作者信息

Patel Pratik, Chen Horng H

机构信息

Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.

出版信息

Curr Hypertens Rep. 2015 Mar;17(3):18. doi: 10.1007/s11906-014-0530-0.

Abstract

Resistant hypertension is defined as blood pressure not under goal despite being on at least three antihypertensives. Resistant hypertension is associated with significant cardiovascular morbidity and mortality. Currently, the mainstay for the treatment of resistant hypertension is lifestyle modification and antihypertensive drugs. Natriuretic peptides play an important role in regulating cardiovascular hemodynamics and sodium and fluid homeostasis including blood pressure control. They hold a promising potential for treatment of resistant hypertension.

摘要

顽固性高血压的定义为,尽管使用了至少三种抗高血压药物,但血压仍未达标。顽固性高血压与显著的心血管发病率和死亡率相关。目前,治疗顽固性高血压的主要方法是生活方式改变和使用抗高血压药物。利钠肽在调节心血管血流动力学以及钠和液体平衡(包括血压控制)方面发挥着重要作用。它们在治疗顽固性高血压方面具有广阔的应用前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验